BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6666162)

  • 1. [Pediatric aspects of success and failure of anti-D-prophylaxis].
    Fürnkranz H; Rosenkranz A
    Wien Med Wochenschr; 1983 Dec; 133(23-24):607-10. PubMed ID: 6666162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-D prophylaxis after abortions and interruptions].
    Maas DH
    Fortschr Med; 1979 Jan; 97(4):148-52. PubMed ID: 217809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successes and failures in rhesus-prophylaxis].
    Speiser P
    Wien Med Wochenschr; 1983 Dec; 133(23-24):595-604. PubMed ID: 6420993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rhesus incompatibility and anti-D prevention in the Düsseldorf region (a ten-year survey) (author's transl)].
    Göbel U; Haering M; Fertmann J; Voss HV; Petrich C
    Dtsch Med Wochenschr; 1975 Oct; 100(40):2010-3. PubMed ID: 808407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum bilirubin level in full-term and premature infants after exchange transfusions.
    Rosta J; Wohlmuth G
    Acta Paediatr Acad Sci Hung; 1966; 7(2):183-93. PubMed ID: 5951017
    [No Abstract]   [Full Text] [Related]  

  • 8. [Phototherapy and treatment with phenobarbital in hemolytic disease of newborn due to Rh-incompatibility].
    Menzel K; Schambach K; Töpke B
    Acta Paediatr Acad Sci Hung; 1974; 15(3-4):333-9. PubMed ID: 4219868
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rhesus-erythroblastosis. Diagnosis, therapy, prevention].
    Maas DH; Schneider J
    Fortschr Med; 1976 May; 94(13):735-40. PubMed ID: 821837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What to do when the infant is jaundiced.
    Wennberg RP
    Med Times; 1971 Nov; 99(11):172-5 passim. PubMed ID: 4939170
    [No Abstract]   [Full Text] [Related]  

  • 11. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of transitory hyperbilirubinemia of the premature and mature newborn infants and of the hemolytic disease of the newborn by an enzyme induction combination: phenobarbital-nikethamide].
    Kintzel HW; Schwarze R; Hinkel GK
    Schweiz Med Wochenschr; 1972 Sep; 102(38):1339-45. PubMed ID: 4630163
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rhesus-prophylaxis during interventions in early pregnancy].
    Beck A
    Wien Med Wochenschr; 1983 Dec; 133(23-24):613-8. PubMed ID: 6420996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Massive fetomaternal hemorrhage and prevention of fetomaternal Rhesus incompatibility. The failure of our present system of prevention].
    Quartier P; Floch C; Meier F; Fruchart MF; Brossard Y; Lejeune C
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(5):517-9. PubMed ID: 8228016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rh (D) alloimmunization and pregnancy. Analysis of the causes after prophylaxis introduction].
    Furundarena JR; Ibisate A; Burguete Y; González de Langarica E; González N; Urquiza R; Mendizabal A; Hernando N; Pérez Clausell C
    Sangre (Barc); 1999 Dec; 44(6):429-33. PubMed ID: 10822755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABO haemolytic disease: sex ratio and blood groups in the newborns requiring treatment.
    Hodr R
    Czech Med; 1989; 12(3):125-33. PubMed ID: 2509171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Obstetrical aspects in successes and failures of rhesus-prophylaxis].
    Reinold E
    Wien Med Wochenschr; 1983 Dec; 133(23-24):610-3. PubMed ID: 6420995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence rate of ABO hemolytic disease of the newborn.
    Katz MA; Kanto WP; Korotkin JH
    Obstet Gynecol; 1982 May; 59(5):611-4. PubMed ID: 7070734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proceedings: Icterus gravis with indirect bilirubin].
    Rubaltelli FF
    Minerva Pediatr; 1973 Oct; 25(37):1563-73. PubMed ID: 4798042
    [No Abstract]   [Full Text] [Related]  

  • 20. Haemolytic disease of the newborn caused by rhesus isoimmunization (anti-c).
    Felc Z
    East Mediterr Health J; 2001 Nov; 7(6):1065-9. PubMed ID: 15332750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.